Normative Data of the Montreal Cognitive Assessment in the Greek Population and Parkinsonian Dementia | Zendy

Kostas Konstantopoulos | Zendy; Paris Vogazianos | Zendy; Triantafyllos Doskas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Normative Data of the Montreal Cognitive Assessment in the Greek Population and Parkinsonian Dementia

Author(s) -

Kostas Konstantopoulos,

Paris Vogazianos,

Triantafyllos Doskas

Publication year - 2016

Publication title -

archives of clinical neuropsychology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.909

H-Index - 98

eISSN - 1873-5843

pISSN - 0887-6177

DOI - 10.1093/arclin/acw002

Subject(s) - dementia , psychology , montreal cognitive assessment , verbal fluency test , population , neuropsychological test , normative , neuropsychological assessment , neuropsychology , discriminant validity , memory span , cognition , clinical psychology , california verbal learning test , psychometrics , audiology , developmental psychology , psychiatry , verbal learning , medicine , cognitive impairment , disease , pathology , internal consistency , philosophy , environmental health , epistemology , working memory

The Montreal Cognitive Assessment (MoCA) is a brief cognitive instrument for the measurement of dementia. The aim of the present study is to provide normative data for the MoCA test in the Greek speaking population and to measure its validity in a clinical group of parkinsonian dementia participants. A total of 710 healthy Greek speaking participants and 19 parkinsonian dementia participants took part in the study. Both, the MoCA test and a neuropsychological test battery (digit span, semantic verbal fluency, phonemic verbal fluency, Color Trails Test) were administered to the normative and clinical samples. The test was found to correlate with all neuropsychological tests used in the test battery and it showed high discriminant validity (optimal screening cutoff point = 21, sensitivity = 0.82, specificity = 0.90) in the parkinsonian dementia participants. Further research is needed to use it in larger clinical samples and in different neurological diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research